Clinical trials
Type 2 Diabetes Patients clinical trials
Below are recruiting type 2 diabetes patients clinical trials, each written for real people, not researchers. We’re tracking 586 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05730582Enrolling by invitation
Improve diabetes screening by using health outreach from records
This trial looks at whether outreach messages sent using your electronic health record can help more adults get diabetes screening. It’s designed for people who are at risk for diabetes but are not already in the clinic’s diabetes registry.
Dallas, TexasAges 18–75 - NCT05689372Enrolling by invitation
Ozempic safety and effectiveness after launch in type 2 diabetes
This study tracks how Ozempic works and whether it stays safe for people with type 2 diabetes in everyday clinic care in Korea. You join because your doctor decides you should start Ozempic, and the study mainly monitors outcomes.
Jeonlabuk-doAges 19 years+ - NCT05576116Enrolling by invitation
Bariatric surgery plus pancreas transplant after kidney transplant
This trial studies whether adding bariatric (weight-loss) surgery and a pancreas transplant can improve health in people with long-term type 2 diabetes who already received a kidney transplant. It may help with blood sugar control and related metabolic health, while also needing careful safety screening for kidney function and blood vessel health.
Toronto, OntarioAges 18–50 - NCT03307486Enrolling by invitation
Study of gestational diabetes during pregnancy
This study follows pregnant people to understand gestational diabetes (high blood sugar during pregnancy) and how it shows up and is monitored. It may help improve future screening and care for gestational diabetes.
São PauloAges Any age - NCT07227805Recruiting
Study of a new automated insulin system for diabetes
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
AntwerpAges 2 years+ - NCT07728669Recruiting
Digital diet app for people on GLP-1 therapy
This study tests a smartphone app that gives dietary advice to people who are overweight or obese and also take a GLP-1 medication (like semaglutide) for weight or diabetes. The app will help you follow a healthy eating plan while using the medication.
AlmatyAges 21–65 - NCT05785780Enrolling by invitation
Help improve colon cancer screening for people with diabetes
This study looks for better ways to make sure people with diabetes get up-to-date colon cancer screening. If you haven’t had the recommended test on time, it may help identify barriers in primary care and improve screening follow-through.
New Brunswick, New JerseyAges 50–74 - NCT07688278Recruiting
Diabetes screening for people with advanced gum disease
This trial tests whether checking blood sugar (HbA1c) at the dentist can find undiagnosed diabetes. It is for adults with advanced periodontitis (severe gum disease) who have not already been told they have diabetes.
SkåneAges 18 years+ - NCT06816303Recruiting
Diabetes Treatment in Liver Transplant Patients and Candidates
This study looks at people with type 2 diabetes who are either waiting for a liver transplant or have already had one. Researchers want to understand how diabetes treatment affects outcomes before and after transplant.
Bologna, BOAges 18 years+ - NCT07297342Recruiting
Comparing ways to use the 'Get Ready' app for weight loss surgery
This study compares two ways of using a smartphone app called 'Get Ready' to help people follow their pre-surgery plan before weight loss surgery. It aims to see which approach helps patients stay on track better.
GeelAges Any age - NCT02166372Recruiting
Testing weight-loss surgery vs standard care for type 2 diabetes
This study compares people with type 2 diabetes and higher body weight who meet criteria for metabolic (weight-loss) surgery versus people with mild obesity who do not. It aims to see whether surgery improves diabetes-related outcomes more than usual medical care.
Taoyuan CityAges 20–67 - NCT05029115Enrolling by invitation
SGLT2 pill study for atrial fibrillation with type 2 diabetes
This trial tests whether an SGLT2 inhibitor pill can help people who have atrial fibrillation (an irregular heartbeat) and type 2 diabetes. You may be eligible if you’re in the right age range, on diabetes pills only, and meet specific heart and lab criteria.
Yangcheon, SeoulAges 20–80 - NCT07063420Recruiting
Diabetes decision support tool for healthcare providers
This trial tests a computer system designed to help doctors choose the best combination of diabetes medications for people with type 2 diabetes. It may help you get more personalized treatment recommendations.
Charlottesville, VirginiaAges 18 years+ - NCT07114445Enrolling by invitation
Virtual reality foot care training for type 2 diabetes
This trial tests if using virtual reality glasses to teach foot care can help people with type 2 diabetes take better care of their feet. It aims to prevent serious foot problems.
Gaziantep, GaziantepAges 18 years+ - NCT05469659RecruitingPhase 2
Test drug to slow kidney damage in type 2 diabetes
This Phase 2 study compares tofogliflozin to metformin to see how well they reduce urine albumin levels (a marker of kidney stress) in people with diabetic kidney disease. You might benefit if your type 2 diabetes is affecting your kidneys despite standard blood-pressure medicines.
Matsumoto, NaganoAges 20 years+ - NCT05662462Recruiting
Phone coaching to keep blood sugar in range during pregnancy
This study tests whether technology plus coaching can help pregnant people with type 2 diabetes keep their blood sugar in a healthy target range. You may use a smartphone app and, if assigned to that group, a device that tracks glucose continuously.
Columbus, OhioAges 18 years+ - NCT06547970Recruiting
Pharmacist education for type 1 diabetes: quality of life and adherence
This study tests whether a pharmacist-led education program can improve quality of life, medication adherence, and satisfaction for people with type 1 diabetes whose blood sugar is not well controlled. It is designed for Arabic-speaking adults and teens 16 and older.
BaghdadAges 16 years+ - NCT06979440Recruiting
Berberine for diabetes with depression
This trial tests if berberine, a natural compound, can improve both blood sugar and mood in people who have type 2 diabetes and major depression. It aims to understand how berberine works at a molecular level.
Nantong, JiangsuAges 18–65 - NCT07165223RecruitingPhase 3
Testing a new insulin for type 2 diabetes
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
Linyi, ShandongAges 18 years+ - NCT07282743RecruitingPhase 2
Study of GL0034 for overweight or obese adults with type 2 diabetes
This trial tests a new medication, GL0034, to see if it helps with weight loss and blood sugar control in people with type 2 diabetes who are overweight. Participants must already be taking metformin and not using other diabetes drugs.
Little Rock, ArkansasAges 18 years+ - NCT07548996RecruitingPhase 2/Phase 3
Study of oral dimethyl fumarate for type 1 diabetes
This study tests an oral capsule called dimethyl fumarate to see if it can help preserve the body’s own insulin production in adults with type 1 diabetes. It may offer a way to slow the loss of beta cells and reduce reliance on insulin.
Nanjing, JiangsuAges 18–65 - NCT05359796Recruiting
Study of long-term type 1 diabetes symptoms and characteristics
This study looks at what day-to-day health and medical features are like in people who have had type 1 diabetes for many years. It may help researchers better understand long-term needs in type 1 diabetes and guide future care.
Changsha, HunanAges Any age - NCT05594706Recruiting
Anhydroglucitol test in children with type 1 diabetes
This trial studies how anhydroglucitol behaves in children with type 1 diabetes who use insulin pump therapy and glucose monitoring. Your team will compare measurements over about a year to see if this marker could be useful for tracking diabetes control.
Geneva, Canton of GenevaAges 2–18 - NCT05641753RecruitingPhase 4
LDL-lowering study for adults with type 1 diabetes
This study looks at cholesterol lowering in adults with type 1 diabetes and whether it reduces “residual risk,” meaning risk that may remain even with current care. You may be asked to take cholesterol-focused treatment and complete blood tests to track LDL (“bad cholesterol”).
New York, New YorkAges 18–89
Hear when a new Type 2 Diabetes Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes patients?
- Yes. Clin2 currently lists 586 recruiting type 2 diabetes patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.